Tag: paralysis
Synchron’s endovascular BCI achieves positive results in US COMMAND study
Synchron has announced positive results from the COMMAND study evaluating the safety and efficacy of the company’s Stentrode brain-computer interface (BCI) device in six...
Synchron announces first use of Apple Vision Pro with brain-computer interface...
Synchron has announced the world’s first-ever use of Apple Vision Pro by one of the patients implanted with the Synchron brain-computer interface (BCI).
Mark, a...
Onward Medical awarded US FDA Breakthrough Device designation for ARC-BCI system
Onward Medical announced recently that it has been awarded Breakthrough Device designation (BDD) by the US Food and Drug Administration (FDA) for the ARC-BCI system, which...
Synchron completes enrolment in US COMMAND trial of endovascular brain-computer interface
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to...
Brain-computer interface plus SCS therapy enables thought-controlled walking after spinal cord...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy....
COMMAND trial set to begin enrolment at third US site
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health...
Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...
Synchron to begin COMMAND trial enrolment at University of Pittsburgh
Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA.
The COMMAND trial is an early...
New white paper details early experience with ABILITY brain-computer interface
A new white paper, released by the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), reveals the first neural signals recorded by the ABILITY...
First US Stentrode implant heralds new field in neurointerventional surgery
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...
Synchron enrols first patient in US COMMAND study of endovascular brain-computer...
Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...
Implantable brain-computer interface enables completely locked-in patient to communicate
Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...
Synchron announces long-term safety results with Stentrode device for severe paralysis
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...
Synchron announces US$10 million NIH grant for US COMMAND trial
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
Synchron given green light to begin US study of endovascular brain-computer...
The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...
